期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

左旋炔诺孕酮近年临床应用 被引量：2

Recently clinical application of levonorgestrel
暂未订购
导出
摘要 左旋炔诺孕酮 (LNG)改变子宫内膜功能。除用于人类节育外 ,其抗子宫内膜增殖活性还被用于在激素替代治疗期间雌激素引起的内膜增殖 ,可能使用于月经过多、痛经、子宫内膜异位 。 Levonorgestrel (LNG) alters the function of the endometrium. This phenomenon offers special health benefits for users, not only for contraception. The antiproliferative effect of the LNG on the endometrium offers targeted therapy against the proliferative action of estrogen on the endometrium during hormone replacement therapy. There are also promising therapeutic fields such as use of the LNG in the treatment of menorrhagia,dysmenorrhea,endometriosis and in the protection of endometrium exposed to tamoxifen during breast cancer treatment.
作者 虞明达
机构地区 安徽省计划生育科学技术研究所
出处 《安徽医药》 CAS 2003年第5期325-327,共3页 Anhui Medical and Pharmaceutical Journal
关键词 左旋炔诺孕酮 临床应用 激素替代治疗 月经过多 痛经 三苯氧胺 levonorgestrel contraception hormone replacement therapy menorrhagia dysmenorrhea tamoxifen
分类号 R979.21 [医药卫生—药品]
  • 相关文献

参考文献16

  • 1[1]Sivin I, Lahteenmaki P, Ranta S et al. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception, 1997;55(2):81～5
  • 2[3]Gu Z, Zhu P, Luo H et al. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ. Contraception, 1995;52(1):57～61
  • 3[4]Zhu P, Liu X, Luo H et al. The effect of levonorgestrel-releasing intrauterine device (20 micrograms/day) (LNG-IUD-20) on the morphological structure of human endometrium: a study of the endometrial factor Ⅷ activity in the women before and after insertion of LNG-IUD-20 by the digital image analysis. Contraception, 1995;52(1):63～8
  • 4童传良.米非司酮用于紧急避孕国际学术研讨会纪要[J].生殖医学杂志,2000,9(6):323-328. 被引量：3
  • 5[6]Worret I, Arp W, Zahradnik HPet al. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase Ⅲ trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology, 2001;203(1):38～44
  • 6[7]Wildemeersch D, Dhont M, Temmerman M et al. GyneFix-LNG: preliminary clinical experience with a copper and levonorgestrel-releasing intrauterine system. Eur J Contracept ReprodHealth Care, 1999;4(1):15～9
  • 7[8]Da Silva MO, Costa MM. Reason, myths and fantasies: preliminary data and reflections about the Portuguese experience with LNG-IUS-induced hypomenorrhea. Eur J Contracept Reprod Health Care, 1999;4(1):21～5
  • 8[9]Paoletti AM, Pilloni M, Orru M et al. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. Maturitas, 2002;42(2):137～47
  • 9[10]Shulman LP, Yankov V, Uhl K. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials. Menopause, 2002;9(3):195～207
  • 10[11]Wildemeersch D, Schacht E. Endometrial suppression with a new "frameless" levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study. Maturitas, 2000;36(1):63～8

共引文献2

同被引文献13

引证文献2

二级引证文献11

安徽医药
2003年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部